APA

van der Ploeg A. P. T., Haydu L. E., Spillane A. J., Scolyer R. A., Quinn M. J., Saw R. P. M., Shannon K. F., Stretch J. R. & Thompson J. F. (20150417). Melanoma patients with an unknown primary tumor site have a better outcome than those with a known primary following therapeutic lymph node dissection for macroscopic (clinically palpable) nodal disease. : Annals of surgical oncology.

Chicago

van der Ploeg Augustinus P T, Haydu Lauren E, Spillane Andrew J, Scolyer Richard A, Quinn Michael J, Saw Robyn P M, Shannon Kerwin F, Stretch Jonathan R and Thompson John F. 20150417. Melanoma patients with an unknown primary tumor site have a better outcome than those with a known primary following therapeutic lymph node dissection for macroscopic (clinically palpable) nodal disease. : Annals of surgical oncology.

Harvard

van der Ploeg A. P. T., Haydu L. E., Spillane A. J., Scolyer R. A., Quinn M. J., Saw R. P. M., Shannon K. F., Stretch J. R. and Thompson J. F. (20150417). Melanoma patients with an unknown primary tumor site have a better outcome than those with a known primary following therapeutic lymph node dissection for macroscopic (clinically palpable) nodal disease. : Annals of surgical oncology.

MLA

van der Ploeg Augustinus P T, Haydu Lauren E, Spillane Andrew J, Scolyer Richard A, Quinn Michael J, Saw Robyn P M, Shannon Kerwin F, Stretch Jonathan R and Thompson John F. Melanoma patients with an unknown primary tumor site have a better outcome than those with a known primary following therapeutic lymph node dissection for macroscopic (clinically palpable) nodal disease. : Annals of surgical oncology. 20150417.